Figure Technology Solutions Inc. Class A Common Stock vs Heron Therapeutics Inc — how do they compare? Figure Technology Solutions Inc. Class A Common Stock trades at $28.01 (market cap $6.19B), while Heron Therapeutics Inc trades at $0.37 (market cap $68.01M). The key difference: Figure Technology Solutions Inc. Class A Common Stock is far larger — about 91× Heron Therapeutics Inc's market cap, and Figure Technology Solutions Inc. Class A Common Stock is more actively traded (4,762,342 versus 1,891,941). Which is the better fit depends on your goals — on Pluang, investors hold Figure Technology Solutions Inc. Class A Common Stock for 0 Days and Heron Therapeutics Inc for 35 Days on average.
| FIGR | HRTX | |
|---|---|---|
Market Cap | $6.19B | $68.01M |
Volume | 4,762,342 | 1,891,941 |
Sector | Financials | Health |
52-Week High | $73.91 | $1.49 |
52-Week Low | $24.91 | $0.27 |
Typical Hold Time | 0 Days | 35 Days |
Enterprise Value | $6.23B | $174.75M |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
HRTX trades at $0.39, up 17.58% today, with a bullish technical signal from moving averages. The company reported Q2 2026 revenue of $37.7 million but missed EPS estimates with a $0.03 loss. Despite negative profitability metrics, analyst consensus remains strongly positive with 89% buy ratings. Recent news highlights ongoing comparisons with peers and earnings performance discussions.
The outlook is mixed: strong analyst support and technical momentum suggest potential upside, but persistent losses and high valuation ratios pose significant risks. Investment opportunity hinges on revenue growth translating to profitability, while key risks include execution challenges and competitive pressures in the biotechnology sector.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Figure Technology Solutions operates a blockchain-native capital marketplace. Its platform supports loan origination, funding, sale, and trading of tokenized assets, along with digital-asset infrastructure and services.
Read more on FIGR →Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →